Xie LiQin, Lin Angela S P, Kundu Kousik, Levenston Marc E, Murthy Niren, Guldberg Robert E
Georgia Institute of Technology, Atlanta, GA, USA.
Arthritis Rheum. 2012 Jun;64(6):1899-908. doi: 10.1002/art.34370. Epub 2012 Jan 9.
To assess temporal changes in cartilage and bone morphology, reactive oxygen species (ROS), and vascularization in rats with monosodium iodoacetate (MIA)-induced osteoarthritis (OA), using advanced imaging methodologies.
Right knees of 8-week-old male Wistar rats were injected with 1 mg MIA in 50 μl saline and left knees were injected with 50 μl saline as controls. After 1, 2, and 3 weeks (n = 5 at each time point), changes in cartilage morphology and composition were quantified using equilibrium partitioning of an ionic contrast agent microfocal computed tomography (μCT), and changes in subchondral and trabecular bone were assessed by standard μCT. ROS were characterized by in vivo fluorescence imaging at 1, 11, and 21 days (n = 5 at each time point). Three weeks following fluorescence imaging, alterations in knee joint vascularity were quantified with μCT after perfusion of a vascular contrast agent.
Femoral cartilage volume, thickness, and proteoglycan content were significantly decreased in MIA-injected knees compared with control knees, accompanied by loss of trabecular bone and erosion of subchondral bone surface. ROS quantities were significantly increased 1 day after MIA injection and subsequently decreased gradually, having returned to normal by 21 days. Vascularity in whole knees and distal femora was significantly increased at 21 days after MIA injection.
Contrast-enhanced μCT and fluorescence imaging were combined to characterize articular cartilage, subchondral bone, vascularization, and ROS, providing unprecedented 3-dimensional joint imaging and quantification in multiple tissues during OA progression. These advanced imaging techniques have the potential to become standardized methods for comprehensive evaluation of articular joint degeneration and evaluation of therapeutic efficacy.
使用先进的成像方法评估碘乙酸钠(MIA)诱导的骨关节炎(OA)大鼠软骨和骨形态、活性氧(ROS)及血管生成的时间变化。
向8周龄雄性Wistar大鼠的右膝注射50 μl盐水中含1 mg MIA,左膝注射50 μl盐水作为对照。在1、2和3周后(每个时间点n = 5),使用离子造影剂微焦点计算机断层扫描(μCT)的平衡分配法对软骨形态和组成的变化进行定量,并通过标准μCT评估软骨下骨和小梁骨的变化。在第1、11和21天通过体内荧光成像对ROS进行表征(每个时间点n = 5)。荧光成像后3周,在灌注血管造影剂后用μCT对膝关节血管生成的改变进行定量。
与对照膝相比,注射MIA的膝部股骨软骨体积、厚度和蛋白聚糖含量显著降低,伴有小梁骨丢失和软骨下骨表面侵蚀。MIA注射后1天ROS数量显著增加,随后逐渐减少,到21天时恢复正常。MIA注射后21天,全膝关节和股骨远端的血管生成显著增加。
将对比增强μCT和荧光成像相结合,以表征关节软骨、软骨下骨、血管生成和ROS,在OA进展过程中提供了前所未有的多组织三维关节成像和定量分析。这些先进的成像技术有可能成为全面评估关节退变和评估治疗效果的标准化方法。